Investing Ideas
/
Australian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Australian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High return on equity, past performance and sound balance sheet.

1 companies

Neuren Pharmaceuticals

Market Cap: AU$2.3b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$18.12

-17.4%

25.8%